FDA Inspection 1323162 — Avara Liscate Pharmaceutical Services SPA

Avara Liscate Pharmaceutical Services SPA — FEI 3004640070

The FDA completed an inspection of Avara Liscate Pharmaceutical Services SPA on February 20, 2026 in Liscate. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 20, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Liscate (Italy)

Additional Details

Mutual Recognition Agreement (MRA)